Compare OIS & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OIS | TOI |
|---|---|---|
| Founded | 1995 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Metal Fabrications | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 565.9M |
| IPO Year | 2000 | N/A |
| Metric | OIS | TOI |
|---|---|---|
| Price | $8.63 | $5.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $14.00 | $6.67 |
| AVG Volume (30 Days) | 756.0K | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.12 | $30.15 |
| Revenue Next Year | $5.89 | $25.77 |
| P/E Ratio | $412.50 | ★ N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $4.75 | $2.32 |
| 52 Week High | $14.50 | $6.67 |
| Indicator | OIS | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 47.87 |
| Support Level | $8.60 | $2.90 |
| Resistance Level | $8.71 | $5.63 |
| Average True Range (ATR) | 0.28 | 0.45 |
| MACD | 0.09 | -0.09 |
| Stochastic Oscillator | 98.48 | 12.73 |
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.